364 related articles for article (PubMed ID: 29990842)
1. LncRNA-NR_033515 promotes proliferation, fibrogenesis and epithelial-to-mesenchymal transition by targeting miR-743b-5p in diabetic nephropathy.
Gao J; Wang W; Wang F; Guo C
Biomed Pharmacother; 2018 Oct; 106():543-552. PubMed ID: 29990842
[TBL] [Abstract][Full Text] [Related]
2. LncRNA NEAT1 accelerates the occurrence and development of diabetic nephropathy by sponging miR-23c.
Li N; Jia T; Li YR
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1325-1337. PubMed ID: 32096162
[TBL] [Abstract][Full Text] [Related]
3. LncRNA NEAT1 promotes extracellular matrix accumulation and epithelial-to-mesenchymal transition by targeting miR-27b-3p and ZEB1 in diabetic nephropathy.
Wang X; Xu Y; Zhu YC; Wang YK; Li J; Li XY; Ji T; Bai SJ
J Cell Physiol; 2019 Aug; 234(8):12926-12933. PubMed ID: 30549040
[TBL] [Abstract][Full Text] [Related]
4. Sp1-Induced lncRNA Rmrp Promotes Mesangial Cell Proliferation and Fibrosis in Diabetic Nephropathy by Modulating the miR-1a-3p/JunD Pathway.
Yang H; Wang J; Zhang Z; Peng R; Lv D; Liu H; Sun Y
Front Endocrinol (Lausanne); 2021; 12():690784. PubMed ID: 34512545
[TBL] [Abstract][Full Text] [Related]
5. The Long Noncoding RNA 150Rik Promotes Mesangial Cell Proliferation via miR-451/IGF1R/p38 MAPK Signaling in Diabetic Nephropathy.
Zhang Y; Sun Y; Peng R; Liu H; He W; Zhang L; Peng H; Zhang Z
Cell Physiol Biochem; 2018; 51(3):1410-1428. PubMed ID: 30485837
[TBL] [Abstract][Full Text] [Related]
6. LncRNA OIP5-AS1 induces epithelial-to-mesenchymal transition and renal fibrosis in diabetic nephropathy via binding to miR-30c-5p.
Fu JX; Sun GQ; Wang HL; Jiang HX
J Biol Regul Homeost Agents; 2020; 34(3):961-968. PubMed ID: 32519534
[TBL] [Abstract][Full Text] [Related]
7. Metformin inhibits extracellular matrix accumulation, inflammation and proliferation of mesangial cells in diabetic nephropathy by regulating H19/miR-143-3p/TGF-β1 axis.
Xu J; Xiang P; Liu L; Sun J; Ye S
J Pharm Pharmacol; 2020 Aug; 72(8):1101-1109. PubMed ID: 32391614
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145/ZEB2 axis.
Liu B; Qiang L; Wang GD; Duan Q; Liu J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3478-3486. PubMed ID: 31081103
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA MEG3 promotes fibrosis and inflammatory response in diabetic nephropathy via miR-181a/Egr-1/TLR4 axis.
Zha F; Qu X; Tang B; Li J; Wang Y; Zheng P; Ji T; Zhu C; Bai S
Aging (Albany NY); 2019 Jun; 11(11):3716-3730. PubMed ID: 31195367
[TBL] [Abstract][Full Text] [Related]
10. lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy.
Meng Q; Zhai X; Yuan Y; Ji Q; Zhang P
Braz J Med Biol Res; 2020; 53(4):e9288. PubMed ID: 32294702
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA TUG1 alleviates extracellular matrix accumulation via mediating microRNA-377 targeting of PPARγ in diabetic nephropathy.
Duan LJ; Ding M; Hou LJ; Cui YT; Li CJ; Yu DM
Biochem Biophys Res Commun; 2017 Mar; 484(3):598-604. PubMed ID: 28137588
[TBL] [Abstract][Full Text] [Related]
12. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
13. MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy.
Gao BH; Wu H; Wang X; Ji LL; Chen C
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1338-1349. PubMed ID: 32096183
[TBL] [Abstract][Full Text] [Related]
14. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A.
Yang J; Shen Y; Yang X; Long Y; Chen S; Lin X; Dong R; Yuan J
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1350-F1358. PubMed ID: 31545928
[TBL] [Abstract][Full Text] [Related]
15. Coptis inhibited epithelial-mesenchymal transition and fibrogenesis of diabetic nephropathy through lncRNA CLYBL-AS2-miR-204-5p-SNAI1 axis.
Cai S; Liu J; Ma Q; Bao Y; Chen J; Li Y
J Drug Target; 2020 Nov; 28(9):939-948. PubMed ID: 32310009
[TBL] [Abstract][Full Text] [Related]
16. Jixuepaidu Tang-1 inhibits epithelial-mesenchymal transition and alleviates renal damage in DN mice through suppressing long non-coding RNA LOC498759.
Jin J; Zhang Z; Chen J; Liu Y; Chen Q; Wang Q
Cell Cycle; 2019 Nov; 18(22):3125-3136. PubMed ID: 31564202
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lncRNA-PAX8-AS1-N directly associated with VEGF/TGF-β1/8-OhdG enhances podocyte apoptosis in diabetic nephropathy.
Shen Y; Tong ZW; Zhou Y; Sun Y; Xie Y; Li R; Liu H
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6864-6872. PubMed ID: 32633379
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of microRNA-93 inhibits TGF-β1-induced EMT and renal fibrogenesis by down-regulation of Orai1.
Ma J; Zhang L; Hao J; Li N; Tang J; Hao L
J Pharmacol Sci; 2018 Apr; 136(4):218-227. PubMed ID: 29551286
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA NEAT1 inhibits high glucose-induced EMT and renal fibrogenesis in Human Embryonic Kidney 293 cells via regulating miR-204/SOX4 axis.
Ahmad Wadaan M; Ahmad M; Hussein Hamzah I
Cell Mol Biol (Noisy-le-grand); 2023 Oct; 69(10):189-194. PubMed ID: 37953563
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of plasmacytoma variant translocation 1 (PVT1) inhibits high glucose-induced proliferation and renal fibrosis in HRMCs by regulating miR-23b-3p/early growth response factor 1 (EGR1).
Yu D; Yang X; Zhu Y; Xu F; Zhang H; Qiu Z
Endocr J; 2021 May; 68(5):519-529. PubMed ID: 33408314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
